Durvalumab plus tremelimumab in unresectable hepatocellular carcinoma
Hepatobiliary Surg Nutr
.
2022 Aug;11(4):592-596.
doi: 10.21037/hbsn-22-143.
Author
Masatoshi Kudo
1
Affiliation
1
Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan.
PMID:
36016731
PMCID:
PMC9396100
DOI:
10.21037/hbsn-22-143
No abstract available
Publication types
Editorial